GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Current Deferred Taxes Liabilities

Piramal Pharma (NSE:PPLPHARMA) Current Deferred Taxes Liabilities : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Piramal Pharma's current deferred tax liabilities for the quarter that ended in Mar. 2024 was ₹0 Mil.

Piramal Pharma Current Deferred Taxes Liabilities Historical Data

The historical data trend for Piramal Pharma's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Current Deferred Taxes Liabilities Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Current Deferred Taxes Liabilities
- - - -

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Piramal Pharma Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Piramal Pharma (NSE:PPLPHARMA) Business Description

Traded in Other Exchanges
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines